Chen R, Guo S, Yang C, Sun L, et al. Although cMYC contributes to tamoxifen resistance, it improves cisplatin sensitivity in ERpositive breast cancer. Int J Oncol 2020 Feb 14. doi: 10.3892/ijo.2020.4987.
PMID: 32319562